Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
QuintilesIMS
Boehringer Ingelheim
Daiichi Sankyo
Fish and Richardson
Citi

Generated: September 22, 2019

DrugPatentWatch Database Preview

Details for Patent: 8,399,508

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Which drugs does patent 8,399,508 protect, and when does it expire?

Patent 8,399,508 protects PATANASE and is included in one NDA.

Protection for PATANASE has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has thirty patent family members in twenty countries.

Summary for Patent: 8,399,508
Title:Olopatadine formulations for topical nasal administration
Abstract: Topical formulations of olopatadine for treatment of allergic or inflammatory disorders of the nose are disclosed. The aqueous formulations contain approximately 0.6% (w/v) of olopatadine.
Inventor(s): Singh; Onkar N. (Arlington, TX), Wall; G. Michael (Fort Worth, TX), Jani; Rajni (Fort Worth, TX), Chowhan; Masood A. (Arlington, TX), Han; Wesley Wehsin (Arlington, TX)
Assignee: Alcon Pharmaceuticals Ltd. (Fribourg, CH)
Application Number:13/173,608
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation;

Drugs Protected by US Patent 8,399,508

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Novartis Pharms Corp PATANASE olopatadine hydrochloride SPRAY, METERED;NASAL 021861-001 Apr 15, 2008 AB RX Yes Yes   Try a Free Trial   Try a Free Trial Y   Try a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,399,508

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 034619   Try a Free Trial
Austria 295149   Try a Free Trial
Australia 2002310461   Try a Free Trial
Brazil 0210707   Try a Free Trial
Brazil PI0210707   Try a Free Trial
Canada 2447924   Try a Free Trial
China 1211125   Try a Free Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Fuji
Merck
Johnson and Johnson
AstraZeneca
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.